June 30, 2016
Marathon Pharmaceuticals Announces Submission of Deflazacort New Drug Application to the FDA
Read More
May 13, 2016
RARECast: Marathon Preps DMD Drug for FDA
Read More
May 9, 2016
Marathon Pharmaceuticals Presents Analyses at AAN of a Phase III Clinical Study of Deflazacort in Patients with Duchenne Muscular Dystrophy (DMD)
Read More
March 11, 2016
Marathon Pharmaceuticals Announces Nationwide Expanded Access Program for Patients with Duchenne Muscular Dystrophy (DMD)
Read More
X